MBL77 - An Overview
Not all sufferers with CLL require therapy. Despite all latest improvements, the iwCLL still endorses watchful observation for people with asymptomatic ailment.86 This advice is predicated on not less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).å¦ç¿’資æ–